The invention also comprises a pharmaceutical composition comprising a first antibody or an antigen binding fragment thereof, and a second antibody, or an antigen binding fragment thereof, wherein the first antibody is an antibody of the invention, and {HEAD ~ the second antibody} is {TAIL ~ an antibody} that neutralizes hCMV infection 
is
The invention also comprises a pharmaceutical composition comprising a first antibody or an antigen binding fragment thereof , and a second antibody , or an antigen binding fragment thereof , wherein the first antibody is an antibody of the invention , and { HEAD ~ the second antibody } is { TAIL ~ an antibody } that neutralizes hCMV infection
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH